• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Vista Gold And 2 Other Stocks Under $2 Insiders Are Buying

    3/22/24 8:58:34 AM ET
    $FRTX
    $RVP
    $VGZ
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $FRTX alert in real time by email

    The Dow Jones index closed higher by over 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

    Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

    Vista Gold

    • The Trade: Vista Gold Corp. (NYSE:VGZ) CFO Douglas L. Tobler acquired a total of 3,500 shares an average price of $0.48. To acquire these shares, it cost around $1,691.
    • What’s Happening: On March 14, Vista Gold posted a fourth-quarter loss of 1 cent per share.
    • What Vista Gold Does: Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects.

    Retractable Technologies

    • The Trade: Retractable Technologies, Inc. (NYSE:RVP) President and CEO Thomas J Shaw acquired a total of 2,147 shares at at an average price of $1.19. To acquire these shares, it cost around $2,555.
    • What’s Happening: On Nov. 14, Retractable Technologies reported that its loss from operations was $8.7 million for the first nine months of 2023.
    • What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.

    Check This Out: Top 3 Tech And Telecom Stocks That Are Ticking Portfolio Bombs

    Fresh Tracks Therapeutics

    • The Trade: Fresh Tracks Therapeutics, Inc. (OTC:FRTX) 10% owner Exploration Capital, LLC acquired a total of 297 shares at an average price of $0.91. The insider spent around $270 to buy those shares.
    • What’s Happening: The company’s stock fell around 6% over the past six months.
    • What Fresh Tracks Therapeutics Does: Fresh Tracks Therapeutics Inc does not have any operations as it has discontinued its activities.

     

    Don’t forget to check out our premarket coverage here

     

    Get the next $FRTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FRTX
    $RVP
    $VGZ

    CompanyDatePrice TargetRatingAnalyst
    Vista Gold Corp
    $VGZ
    7/26/2021$3.25 → $3.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $FRTX
    $RVP
    $VGZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vista Gold Announces 2025 Financial Results

    Vista Gold Corp. (NYSE American and TSX:VGZ) today announced its audited financial results for the year ended December 31, 2025, with cash totaling $13.6 million at year-end. All dollar amounts in this press release are in U.S. dollars. Frederick H. Earnest, President and CEO of Vista, stated, "2025 was a pivotal year for our Company. The completion of the new Mt Todd Feasibility Study in July 2025 was a defining moment for the Mt Todd gold project and Vista. The study demonstrates an achievable path to near-term production centered on a smaller initial operation that prioritizes higher grade ore to the processing plant, significantly lowers initial capital costs, and incorporates contrac

    3/11/26 5:01:00 PM ET
    $VGZ
    Precious Metals
    Basic Materials

    Vista Gold Corp. Announces Closing of US$44.85 Million Public Offering of Common Shares and Full Exercise by the Underwriters of Option to Purchase Additional Common Shares

    Vista Gold Corp. (NYSE American and TSX:VGZ) ("Vista" or the "Company") is pleased to announce the closing of its previously announced underwritten public offering of 17,940,000 of its common shares, which includes the full exercise of the underwriters' option to purchase 2,340,000 additional common shares, at a price to the public of US$2.50 per share. The total gross proceeds to Vista were US$44.85 million, before deducting underwriting discounts and commission and other offering expenses payable by Vista. The Company intends to allocate the net proceeds from the offering to advance exploration and development activities at the Company's Mt. Todd gold project, a development-stage gold

    3/9/26 9:45:00 AM ET
    $VGZ
    Precious Metals
    Basic Materials

    Vista Gold Corp. Announces Pricing of US$39.0 million Public Offering of Common Shares

    DENVER, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Vista Gold Corp. (NYSE American and TSX:VGZ) ("Vista" or the "Company") is pleased to announce the pricing of its previously announced underwritten public offering of 15,600,000 of its common shares at a price to the public of US$2.50 per share. The total gross proceeds to Vista are expected to be US$39.0 million, before deducting underwriting discounts and commission and other offering expenses payable by Vista. The offering is expected to close on March 9, 2026, subject to the satisfaction of customary closing conditions, including the approval of the NYSE American and the Toronto Stock Exchange. In addition, Vista has granted the underwriters

    2/26/26 9:42:26 AM ET
    $VGZ
    Precious Metals
    Basic Materials

    $FRTX
    $RVP
    $VGZ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT AND CEO Shaw Thomas J bought $4,424 worth of shares (5,731 units at $0.77), increasing direct ownership by 0.04% to 15,831,222 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/17/25 11:29:38 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $81 worth of shares (100 units at $0.81), increasing direct ownership by 0.00% to 15,825,491 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/13/25 1:29:23 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $6,195 worth of shares (7,500 units at $0.83), increasing direct ownership by 0.05% to 15,825,391 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/6/25 10:53:09 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $FRTX
    $RVP
    $VGZ
    SEC Filings

    View All

    Vista Gold Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - VISTA GOLD CORP (0000783324) (Filer)

    3/11/26 5:05:25 PM ET
    $VGZ
    Precious Metals
    Basic Materials

    SEC Form 10-K filed by Vista Gold Corp

    10-K - VISTA GOLD CORP (0000783324) (Filer)

    3/11/26 4:04:46 PM ET
    $VGZ
    Precious Metals
    Basic Materials

    Vista Gold Corp filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - VISTA GOLD CORP (0000783324) (Filer)

    3/9/26 5:27:58 PM ET
    $VGZ
    Precious Metals
    Basic Materials

    $FRTX
    $RVP
    $VGZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Former 10% Beneficial Owner Sun Valley Gold Llc sold $880,000 worth of shares (400,000 units at $2.20) (SEC Form 4)

    4 - VISTA GOLD CORP (0000783324) (Issuer)

    12/29/25 8:47:29 AM ET
    $VGZ
    Precious Metals
    Basic Materials

    Large owner Sun Valley Gold Llc sold $1,873,066 worth of shares (880,744 units at $2.13) (SEC Form 4)

    4 - VISTA GOLD CORP (0000783324) (Issuer)

    12/22/25 7:43:00 PM ET
    $VGZ
    Precious Metals
    Basic Materials

    PRESIDENT AND CEO Shaw Thomas J bought $4,424 worth of shares (5,731 units at $0.77), increasing direct ownership by 0.04% to 15,831,222 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/17/25 11:29:38 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $FRTX
    $RVP
    $VGZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HC Wainwright & Co. reiterated coverage on Vista Gold with a new price target

    HC Wainwright & Co. reiterated coverage of Vista Gold with a rating of Buy and set a new price target of $3.00 from $3.25 previously

    7/26/21 9:34:15 AM ET
    $VGZ
    Precious Metals
    Basic Materials

    $FRTX
    $RVP
    $VGZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Fresh Tracks Therapeutics Inc.

    SC 13D - Fresh Tracks Therapeutics, Inc. (0000819050) (Subject)

    5/8/24 4:01:47 PM ET
    $FRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Fresh Tracks Therapeutics Inc. (Amendment)

    SC 13G/A - Fresh Tracks Therapeutics, Inc. (0000819050) (Subject)

    1/17/24 8:37:18 PM ET
    $FRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13D filed by Vista Gold Corp

    SC 13D - VISTA GOLD CORP (0000783324) (Subject)

    3/13/23 4:55:23 PM ET
    $VGZ
    Precious Metals
    Basic Materials

    $FRTX
    $RVP
    $VGZ
    Financials

    Live finance-specific insights

    View All

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2025 through December 31, 2025. The dividends will be paid on January 20, 2026 to shareholders of record as of the close of business on January 10, 2026. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and

    12/30/25 4:14:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Vista Gold Highlights Mt Todd Milestones and Announces Third Quarter 2025 Financial Results

    Vista Gold Corp. (NYSE American and TSX:VGZ) today announced its unaudited financial results for the quarter ended September 30, 2025, with cash totaling $13.7 million at quarter-end. All dollar amounts in this press release are in U.S. dollars. Frederick H. Earnest, President and CEO of Vista, said, "In the third quarter, Vista completed a feasibility study for Mt Todd that presents a fresh vision for the project as a 15,000 tonne per day operation – one that prioritizes lower initial capital costs and higher ore grades. It also incorporates proven Australian design and operating practices that reduce risk, simplify construction, and support long-term operational success over a 30-year m

    11/12/25 5:07:00 PM ET
    $VGZ
    Precious Metals
    Basic Materials

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2025 through September 30, 2025. The dividends will be paid on October 20, 2025 to shareholders of record as of the close of business on October 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV

    9/30/25 2:06:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $FRTX
    $RVP
    $VGZ
    Leadership Updates

    Live Leadership Updates

    View All

    /C O R R E C T I O N -- Fresh Tracks Therapeutics, Inc./

    In the news release, Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution, issued 27-Jan-2025 by Fresh Tracks Therapeutics, Inc. over PR Newswire, we are advised by the company that the reference to "...first quarter of 2024" at the end of the first paragraph was incorrectly stated and should read "...first quarter of 2025". The complete, corrected release follows: Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution BOULDER, Colo., Jan. 27, 2025 /PRNewswire/ -- Fresh Tracks Therapeutics, Inc. (OTC:FRTX) ("Fresh Tracks" or "the Company") announced today that the Court of Chancery of the State of Delaware ("the Court") has g

    1/27/25 4:05:00 PM ET
    $FRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution

    BOULDER, Colo., Jan. 27, 2025 /PRNewswire/ -- Fresh Tracks Therapeutics, Inc. (OTC:FRTX) ("Fresh Tracks" or "the Company") announced today that the Court of Chancery of the State of Delaware ("the Court") has granted the consent judgment agreed to by the Company in the case of David R. McAvoy versus Fresh Tracks, as a result of which the Court has appointed Albert N. Marchio II, Chief Executive Officer and Chief Financial Officer of Fresh Tracks, as the custodian of Fresh Tracks pursuant to 8 Del. C. § 226 with a directive to dissolve the Company and wind up its affairs. Fresh Tracks currently anticipates it will complete the dissolution and make a distribution of between $0.95 and $0.98 per

    1/27/25 4:05:00 PM ET
    $FRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company

    BOULDER, Colo., June 17, 2024 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (OTC:FRTX) ("Fresh Tracks" or the "Company") announced today that it has filed an Answer (the "Answer") to a Verified Petition for Appointment of a Custodian Pursuant to 8 Del. C. § 226 (the "Delaware Petition") that was filed with the Court of Chancery of the State of Delaware (the "Court") on May 17, 2024 by a stockholder and former General Counsel, Chief Compliance Officer, and Secretary of the Company, David R. McAvoy (the "Petitioner"). The Delaware Petition, to which the Answer outlines the Company is in overall agreement with, specifically requests that the Court issue an order appointing Albert N. Ma

    6/17/24 4:05:00 PM ET
    $FRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care